Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Infleqtion Reports Record Q2 Revenue, Raises 2026 Outlook as Quantum Commercialization Accelerates
-
Virgin Galactic Announces Second Quarter 2026 Financial Results and Provides Business Update
-
Century Communities Announces Quarterly Cash Dividend
-
Global Crossing Airlines Reports Second Quarter 2026 Financial Results
-
QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale
-
Armata Pharmaceuticals Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update
-
PEOPLE and Great Place To Work Name Bright Horizons to 2026 PEOPLE Companies that Care List
-
Knightscope Reports Record Second Quarter 2026 Financial Results
-
Supermicro Announces Participation in Upcoming Investor Events
-
Cerebras Systems Fast Inference Cloud Business Nearly Quadruples in Second Quarter 2026
-
Hongli Group Inc. Announces Compliance with Nasdaq Minimum Bid Price Requirement
-
Comscore Reports Second Quarter 2026 Results
-
NANO Nuclear Reports Q3 FY 2026 Financial Results and Provides Business Update
-
RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth
-
Forward Industries Reports Fiscal Third Quarter 2026 Financial and Operating Results
-
ITG, Inc. Reports Second Quarter 2026 Results
-
Lumexa Imaging Announces Second Quarter 2026 Results
-
MaxCyte Reports Second Quarter 2026 Financial Results
-
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
-
Acrivon Reports Second Quarter 2026 Financial Results and Highlights Upcoming 2026 Clinical Data Catalysts
-
Nortech Systems Reports Second Quarter Results
-
Enovix Reports Second Quarter 2026 Results
-
Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates
-
Byrna Appoints Retired U.S. Army Brigadier General Rose Lopez Keravuori to Board of Directors
-
Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update
-
Robinhood Markets, Inc. Reports July 2026 Operating Data
-
Coherent Corp. Reports Fourth Quarter and Full Year Fiscal 2026 Results
-
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
-
Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update
-
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
-
Nordique Critical Metals Provides Update on Kwyjibo Rare Earth Project
-
CuriosityStream Delivers Record Q2 Earnings as Licensing Momentum Drives $8.9 million in Net Income and $11.4 million in Adjusted EBITDA; Raises Full-Year Outlook
-
2026's Top CRM Platforms Named Champions in Info-Tech Research Group's Data Quadrant Reports
-
Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights
-
Liftoff Mobile Announces Second Quarter 2026 Financial Results
-
Omeros Corporation Reports Second Quarter 2026 Financial Results
-
Kura Oncology Reports Second Quarter 2026 Financial Results
-
Mannatech Reports Financial Results for Second Quarter 2026
-
CORRECTING and REPLACING VORAGO Climbs 2026 Inc. 5000 List for 5th Year, Driving Growth in Extreme Radiation- and Thermal-Protected Satellite and Space Chips
-
Falcone Sovereign Wealth Partnership Group Advances Tanzani Initiative Following High-Level Government Engagement
-
STAAR Surgical Reports Second Quarter 2026 Results
-
Presurance Holdings Reports 2026 Second Quarter Financial Results
-
ArriVent BioPharma Reports Second Quarter 2026 Financial Results
-
Alpha and Omega Semiconductor Reports Financial Results for Fiscal Fourth Quarter and Fiscal Year Ended June 30, 2026
-
REKLAIM ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING
-
PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program
-
AEVEX Corp. Announces Financial Results for Second Quarter 2026
-
Sangamo Therapeutics Selects Successful Bidders Following Competitive Asset Auction for $163.55 Million in Cash Consideration at Closing and Up to $100 Million in Potential Milestones
-
WhiteFiber and Krambu Partner to Bring 100MW of High-Density GPU Infrastructure Capacity to Market in 2027
-
FormFactor Announces Participation at Upcoming Conferences
